SGMT Market Cap History Table | ||||||||||
Also see: SGMT Shares Outstanding History and SGMT YTD Return |
SGMT Market Cap History Table | ||||||||||
Also see: SGMT Shares Outstanding History and SGMT YTD Return |
SGMT Market Cap History Chart | ||||||||||||
-89.95% CAGR Mouse over chart for data details
|
SGMT Stock Price Chart |
About Sagimet Biosciences Inc |
Sagimet Biosciences is a clinical-stage biopharmaceutical company developing therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Co.'s primary drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). Co. is testing denifanstat in its FASCINATE-2 Phase 2b clinical trial in NASH. Co. is also evaluating the promise of FASN inhibition in other disease areas in which dysregulation of fatty acid metabolism also plays a role, including in acne and certain forms of cancer. We show 4 historical shares outstanding datapoints in our SGMT shares outstanding history coverage, used to compute SGMT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SGMT market cap history over the course of time is important for investors interested in comparing SGMT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SGMT versus a peer is one thing; comparing SGMT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SGMT can fluctuate over the course of history. With this page we aim to empower investors researching SGMT by allowing them to research the SGMT market cap history. |
SGMT Current Stock Quote |
Free SGMT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SGMT Share Performance |
Market Cap Peers |
Sagimet Biosciences (SGMT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SGRY Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.